Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
about
sameAs
Personalized medicine in major depressive disorder -- opportunities and pitfallsBiomarkers of Parkinson's disease: present and futureIdentification of new epilepsy treatments: issues in preclinical methodologyTranslational biomarker discovery in clinical metabolomics: an introductory tutorialWhat are biomarkers?Marital quality and health: a meta-analytic reviewReboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trialsPeripheral biomarkers of endometriosis: a systematic reviewAttentional bias toward suicide-related stimuli predicts suicidal behaviorToward imaging biomarkers for glycosaminoglycansA perfect correlate does not a surrogate makeFrom bench to clinic and back: Perspective on the 1st IQPC Translational Research conferenceTear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicineCancer pharmacogenomics, challenges in implementation, and patient-focused perspectivesBlood Biomarkers for Evaluation of Perinatal EncephalopathyTuberculosis Biomarkers: From Diagnosis to ProtectionCirculating Biomarkers of Diabetic Retinopathy: An Overview Based on PhysiopathologyRevolutionizing Alzheimer's disease and clinical trials through biomarkersChallenges in translating endpoints from trials to observational cohort studies in oncologymiR-155 as a Biomarker in B-Cell MalignanciesBiomarkers of alcohol misuse: recent advances and future prospectsNetwork-Based Protein Biomarker Discovery PlatformsEpigenetic Biomarkers of Preterm Birth and Its Risk FactorsDiabetes Mellitus, Arterial Wall, and Cardiovascular Risk AssessmentEmerging role of novel biomarkers in the diagnosis of inflammatory bowel diseaseRole of Hybrid Brain Imaging in Neuropsychiatric DisordersEarly Dementia ScreeningModeling Kidney Disease with iPS CellsDynamics of circulating microparticles in chronic kidney disease and transplantation: Is it really reliable marker?Making Sense of Blood-Based Proteomics and Metabolomics in Psychiatric ResearchmiRNAs Regulation and Its Role as Biomarkers in EndometriosisCirculating MicroRNAs as Biomarkers for SepsisKidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical PracticeBioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative DisordersCardiac Troponins in Dogs and CatsThe role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sicknessBiomarkers for physical frailty and sarcopenia: state of the science and future developmentsAllergen Immunotherapy (AIT): a prototype of Precision MedicineNitroxide pharmaceutical development for age-related degeneration and diseasePredictive biomarkers for treatment selection: statistical considerations
P2860
Q24170133-BE92CA5E-16E3-4CFB-A24F-D57ACAA70D49Q24170134-F22BE47D-DD10-4987-9640-9DD9CFF7BC62Q24289140-4B6102EE-F181-4B8F-BCC5-025FFF18385CQ24598642-5C94781B-C300-4BF9-8559-07464480A61AQ24613362-CBBA5467-42C4-4F2D-BEC0-456E66387972Q24626999-F0A28E90-B545-4358-8B15-D828226DEBAFQ24632255-DEFA09AA-2D04-40B0-900D-9205D01EEC0FQ24632541-DCD6C960-1FE6-4ADD-88C0-4C0A091CF1F8Q24633217-6A095AFA-C50B-48BE-B74F-89E332667B7EQ24649985-6F5979CB-7067-41E3-9A8A-411A3FF36F44Q24803339-BB1F5BD4-067F-4ECE-B20E-B1B6C90608C4Q24803350-877DD1BC-69EC-46DE-AAB0-1988471A5A96Q26740411-B38D0A06-D49C-4F2F-86D4-5C6972DDAE3AQ26741009-D9E703A7-F40A-4734-8C49-D9D02167E7CCQ26741134-63FD6384-7698-4D27-B225-6D9B494DBAF5Q26741141-73DEB927-2258-4658-B899-761547854D9BQ26744760-3F81A44E-0990-439D-80CD-6555A6FE8F47Q26744882-0799FD52-892C-4BA2-AE54-B48E528ABE0BQ26746190-56D8A0C9-5ACF-4128-A59A-6AE5A86ACCF1Q26746573-0158C0C0-FB45-4355-85B7-5449E414890FQ26746815-8A661456-C0D9-4705-8FD8-EFE9B7736CC6Q26751123-AAF451BB-0913-4112-9162-91B34B03D0F1Q26752730-08474456-A20E-44F4-ABCA-15BB84D60BBAQ26767215-95A60E7C-8C0C-4677-BB30-FD15138A3790Q26768273-EB8D05A1-014A-4B32-A3F0-594EA10F7859Q26768454-06BB142A-9F76-42EB-A4D6-EEAB606E58C9Q26770171-5D908B9C-1083-4A6B-AE58-82671CED79B4Q26770384-FCF26B48-916F-4F56-B55B-1F2B3E7590E7Q26771389-690A1D8E-21FA-4335-A1D3-31AE55E03B0BQ26771434-BD84C568-51B2-4AA8-A92D-A0BC0ECAB1C8Q26771724-E89B0860-7B87-48C8-9787-3230BB34A5E6Q26772133-7EB61F0A-6B78-4EF2-BEC2-878330FF289FQ26772195-122EE25D-2CC7-46C9-82F0-3EB16E35C875Q26774418-9D330653-511A-4C7E-8A65-8C4D77A16BD7Q26774969-9955AA26-7D39-4FB0-93FE-66D03A1DB6BBQ26775041-48B20B92-44F5-4393-AFE7-FC941C15365CQ26775328-4036EB94-1825-49D4-9A48-8D27E8FA967EQ26776512-548618D2-DB81-4168-9840-46F9FDF13E51Q26776523-1E79CD6F-CF11-469D-9D3A-18990ED5CC0AQ26778367-619CF5B5-2769-489D-9F24-6F9C512AD305
P2860
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
@ast
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
@en
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
@nl
type
label
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
@ast
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
@en
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
@nl
prefLabel
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
@ast
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
@en
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
@nl
P3181
P356
P1476
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
@en
P3181
P356
10.1067/MCP.2001.113989
P407
P577
2001-03-01T00:00:00Z